Novo says FDA to hold adcom for liraglutide

Novo Nordisk A/S (CSE:NVO; NYSE:NVO) said FDA has tentatively scheduled an advisory committee meeting on Sept. 11 to discuss an NDA for a 3 mg dose of liraglutide as an adjunct to diet and exercise fo...